SEK241.00
1.03% today
Stockholm, Sep 03, 03:03 pm CET
ISIN
SE0000135485
Symbol
RAY B

RaySearch Laboratories Stock price

SEK243.50
-80.00 24.73% 1M
-3.50 1.42% 6M
+27.50 12.73% YTD
+91.10 59.78% 1Y
+195.78 410.25% 3Y
+149.64 159.44% 5Y
+131.26 116.94% 10Y
+191.30 366.50% 20Y
Stockholm, Closing price Tue, Sep 02 2025
-11.50 4.51%
ISIN
SE0000135485
Symbol
RAY B

Key metrics

Basic
Market capitalization
SEK8.7b
Enterprise Value
SEK8.8b
Net debt
SEK27.2m
Cash
SEK402.8m
Shares outstanding
34.3m
Valuation (TTM | estimate)
P/E
43.3 | 35.9
P/S
7.0 | 6.3
EV/Sales
7.0 | 6.4
EV/FCF
52.4
P/B
10.3
Dividends
DPS
SEK3.00
Yield 1Y | 5Y
1.2% | 0.9%
Growth 1Y | 5Y
328.6% | -
Payout 1Y | 3Y
50.5% | 55.5%
Increased
2 Years
Financials (TTM | estimate)
Revenue
SEK1.3b | SEK1.4b
EBITDA
SEK431.7m | SEK635.0m
EBIT
SEK246.6m | SEK330.1m
Net Income
SEK193.0m | SEK232.5m
Free Cash Flow
SEK167.3m
Growth (TTM | estimate)
Revenue
11.0% | 15.7%
EBITDA
5.0% | 22.2%
EBIT
31.7% | 26.7%
Net Income
27.6% | 14.3%
Free Cash Flow
-50.4%
Margin (TTM | estimate)
Gross
91.5%
EBITDA
34.5% | 46.1%
EBIT
19.7%
Net
15.4% | 16.9%
Free Cash Flow
13.4%
Financial Health
Equity Ratio
41.9%
Return on Equity
23.2%
ROCE
18.7%
ROIC
19.4%
Debt/Equity
0.5
More
EPS
SEK5.6
FCF per Share
SEK4.9
Short interest
-
Employees
416
Rev per Employee
SEK2.9m
Show more

Is RaySearch Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

RaySearch Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a RaySearch Laboratories forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a RaySearch Laboratories forecast:

Buy
89%
Hold
11%

Financial data from RaySearch Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,253 1,253
11% 11%
100%
- Direct Costs 107 107
0% 0%
9%
1,146 1,146
12% 12%
91%
- Selling and Administrative Expenses 617 617
9% 9%
49%
- Research and Development Expense 86 86
2% 2%
7%
432 432
5% 5%
34%
- Depreciation and Amortization 185 185
17% 17%
15%
EBIT (Operating Income) EBIT 247 247
32% 32%
20%
Net Profit 193 193
28% 28%
15%

In millions SEK.

Don't miss a Thing! We will send you all news about RaySearch Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. Its products and services are divided into three categories: RayStation, Partner Products, and Research. RayStation is the company's proprietary treatment planning system. Partner Products include proton and intensity modulated radiation therapy, automatic treatment planning, quality assurance, and radiobiology. Research offers long term study of new methods and techniques in radiation treatment. The company was founded by Johan Löf, Erik Hedlund, Carl Filip Bergendal, Anders Brahme, Bengt Lind, and Anders Liander in 2000 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Johan Löf
Employees 416
Founded 2000
Website www.raysearchlabs.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today